Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4604)
All Articles published online
|
Publishing Process of This Article
|
Jan 27, 2025 (publication date) through Mar 28, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Shi J, Zhu X, Yang JB. Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer. World J Hepatol 2025; 17(1): 102273 [PMID: 39871899 DOI: 10.4254/wjh.v17.i1.102273] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Shi J, Zhu X, Yang JB. Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer. World J Hepatol 2025; 17(1): 102273 [PMID: 39871899 DOI: 10.4254/wjh.v17.i1.102273] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i1/102273.htm |
| Number | Citing Articles |
| 1 |
Murat Isıyel, Hamid Ceylan, Yeliz Demir. Integrated bioinformatics and molecular docking ıdentify CCNB1, CDK1, and CYP1A2 as therapeutic targets of phytochemicals in hepatocellular carcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(3): 4129 doi: 10.1007/s00210-025-04729-0
|
| 2 |
Baozhu Zhang, Muhammad Sohaib Iqbal, Yibin Yan, Han Wang, Xuejin Wang, Yinghe Zhang, Bing Guo. Next-generation dynamic and combinatorial nanotherapies for liver cancer: mechanisms, current advances and future perspectives. Journal of Nanobiotechnology 2026; 24(1) doi: 10.1186/s12951-026-04102-0
|
| 3 |
Noura A A Ebrahim, Thoraya A Farghaly, Ahmed Abdo El-Sherif, Ahmed M Fahmy, Moamen O Othman, Neveen S Tahoun, Omnia Mohamed Korany, Aya Arafat, Reham Oreaba, Soliman M A Soliman. Clinicopathological insights and management of liver metastases: Current advances and future perspectives. World Journal of Hepatology 2025; 17(10): 110026 doi: 10.4254/wjh.v17.i10.110026
|
| 4 |
Qian Wang. Targeted therapy for liver cancer: Current status and future directions. BioImpacts 2025; 15: 32630 doi: 10.34172/bi.32630
|
| 5 |
Mozhdeh Meghdadian, Niyaz Mohammad Mahmoodi. Dual-functional materials (catalysts and adsorbents) as innovative and sustainable pathways toward combined healthcare (antibacterial, antifungal, antiviral, antioxidant, and anticancer properties) and water pollution remediation. Journal of Environmental Chemical Engineering 2025; 13(5): 117718 doi: 10.1016/j.jece.2025.117718
|
| 6 |
Tian-Ze Li, Feng-Dan Huang, Jia-Xin Yan, Min-Min Hu, Feng-Jiao Li, Yun-Bao Ma, Ya-Bo Li, Wen-Jing Ma, Yong-Cui Wang, Ji-Jun Chen. Discovery of dimeric guaianolides with all carbon linkers as potential antihepatoma agents. European Journal of Medicinal Chemistry 2025; 300: 118160 doi: 10.1016/j.ejmech.2025.118160
|
| 7 |
Poonam Sahu, Trilochan Satapathy. Liver targeted nanomedicine for treatment of fibrosis and hepatocellular carcinoma: Emerging strategies in ligand-guided, stimuli-responsive and gene-based delivery. Journal of Drug Delivery Science and Technology 2026; 116: 107935 doi: 10.1016/j.jddst.2025.107935
|
| 8 |
Zilong Zhang, Xiaoping Chen, Bixiang Zhang, Wanguang Zhang, Ze-yang Ding. Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2026; 1881(1): 189517 doi: 10.1016/j.bbcan.2025.189517
|
| 9 |
Mariam Ayad Abd, Mohammed Asiri, Shahd Rajab Farhan, Gaurav Sanghvi, Rangaswamy Roopashree, Aditya Kashyap, D. Alex Anand, Rajashree Panigrahi, Yasser Fakri Mustafa, Baneen C. Gabaal. Update on Application of Oncolytic Virus‐Based Combination Therapy in the Treatment of Hepatocellular Carcinoma. Journal of Biochemical and Molecular Toxicology 2025; 39(6) doi: 10.1002/jbt.70327
|
| 10 |
Tianyi Hang, Danfeng Fan, Tiefeng Sun, Zhengyuan Chen, Xiaoqing Yang, Xiaoqing Yue. Deep Learning and Hyperspectral Imaging for Liver Cancer Staging and Cirrhosis Differentiation. Journal of Biophotonics 2025; 18(4) doi: 10.1002/jbio.202400557
|
| 11 |
Olga Y. Burenina, Roman K. Makarchenko, Maria P. Rubtsova, Olga A. Dontsova. Liver‐specific lncRNAs associated with liver cancers. FEBS Open Bio 2025; 15(9): 1383 doi: 10.1002/2211-5463.70079
|
| 12 |
D. Anandkumar, S. John Justin Thangaraj, C. Alamelu, M. Vallikkannu. Liver Tumor Classification in CT Images Using Prognostic Assimilate Learning Classifier (PALC). 2025 2nd International Conference on Electronic Circuits and Signaling Technologies (ICECST) 2025; : 887 doi: 10.1109/ICECST66106.2025.11307248
|
| 13 |
Wen-Jing Ma, Qi-Hao Li, Jing Hu, Yong-Cui Wang, Yun-Bao Ma, Ji-Jun Chen, Tian-Ze Li. Discovery of guaianolide-eudesmanolide dimers as antihepatoma agents by targeting NEURL1B to disrupt the DLL1/Notch signaling pathway. Bioorganic Chemistry 2026; 174: 109735 doi: 10.1016/j.bioorg.2026.109735
|